Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288123-10-000006
Filing Date
2010-01-21
Accepted
2010-01-21 11:29:58
Documents
1
Period of Report
2010-01-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5069
  Complete submission text file 0001288123-10-000006.txt   6854
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Issuer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ANTIGENICS INC. 630 FIFTH AVE., SUITE 2100 NEW YORK NY 10111
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 10538056